Connie B. Newman, MD, FACP, FAHA, FAMWA

Connie B. Newman MD FACP FAMWA, President-elect of the American Medical Women’s Association (AMWA), is an endocrinologist, physician-scientist and Adjunct Professor of Medicine at New York University (NYU) School of Medicine, and Academic Visitor, University of Oxford, UK. She has expertise in statin safety, lipid disorders, and obesity, and has published and lectured on statin safety and intolerance for many years. She is a member of the Cholesterol Treatment Trialists’ Collaboration which conducts meta-analyses of large statin outcome trials. She is Chair of the Endocrine Society clinical practice guideline on the management of high cholesterol and Chair of the American Heart Association Scientific Statement on statin safety. She has been appointed a Consultant to the Endocrine and Metabolic Drugs Advisory Committee of the FDA.

Dr. Newman is committed to increasing access to health care in underserved areas globally, and has served for many years on the American Women’s Hospitals Service committee as a member and Co-Chair. She advocates for women’s reproductive rights, gender equity, and research in both women and men. She serves on the Planned Parenthood (PP) Board of Northern, Central and Southern NJ, the PP Global Advisory Board, and the PP National Medical Committee. Dedicated to helping advance women in medicine, she mentors students, and young physicians through AMWA, NYU, Weill Cornell Medicine, and the Wellesley Women in Medicine group that she founded in 2011.

Dr. Newman has been a faculty member of NYU School of Medicine since 1984. She worked in the pharmaceutical industry between 1998 and 2007, and was Head of Regulatory Affairs for the cardiovascular franchise at Pfizer, Inc. She is a graduate of Wellesley College and Weill Cornell Medical College. She is married and has three children.

Return to 2017 Interim